News

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

ST. PAUL, Minn., June 10, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today…

7 months ago

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma…

7 months ago

Rad AI Named to CNBC Disruptor 50 List For Pioneering Generative AI in Healthcare

Recognition comes amid rapid growth, with Rad AI recently securing $68 million in Series C Funding and ranking 19th on…

7 months ago

Southwest General Partners with Notable to Close Care Gaps and Redefine Patient Access

The health center will leverage Notable's AI Platform to automate highly manual processes, including registration, intake, and care gap outreach…

7 months ago

Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution

The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building,…

7 months ago

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Study is Intended to Verify Previous Discovery Results Demonstrating Sensitivity of 95% and Specificity of 98%BERKELEY, Calif. and MAINZ, Germany,…

7 months ago

NeuroSigma Announces Notice of Allowance for Patent Protecting Monarch eTNS System in China

LOS ANGELES, June 10, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve…

7 months ago

Roji Health Intelligence Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity

HITRUST e1 Certification validates Roji Health Intelligence is committed to foundational cybersecurity controls and information risk managementCHICAGO, June 10, 2025…

7 months ago

Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension

NORCROSS, Ga., June 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3…

7 months ago

Iovance Biotherapeutics to Present at Upcoming Conference

SAN CARLOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating,…

7 months ago